GGrantIndex
← Leaderboards

Daniel Kulp

Wistar Institute

$6,786,029
Attributed
$6,786,029
Total exposure
4
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $4.1M · FY202125
$5M$3.8M$2.5M$1.3M$0
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$9,412,843 · 5

By mechanism

P01$4,157,213 · 2
U19$2,901,446 · 1
R01$1,850,852 · 1
R21$503,332 · 1

Top collaborators

Most similar at Wistar Institute

Same institution · by research overlap

Others in their field

Other Emerging Leaders on “Virus

Research focus

VirusB-LymphocytesImmunizationAntigensVaccinesNanoparticleEpitopesMutationDesignAntibodiesNeutralizing AntibodyFrequenciesInvestigationAntibody RepertoireAnimalsResponseStructureBinding SitesProgramsGeneticImmune ResponseImmunityLead CandidatePre-Clinical

Grant awards (11)

Refinement of DNA-Launched NanoParticles decorated with Apex and CD4bs B cell lineage targeting Envs (DLNP-ACEs)$596,083
U19 · FY2025 · AI · contact PI
Development of broad nanovaccines targeting diverse coronavirus receptor-binding sites$285,928
P01 · FY2025 · AI · contact PI
Refinement of DNA-Launched NanoParticles decorated with Apex and CD4bs B cell lineage targeting Envs (DLNP-ACEs)$1,141,993
U19 · FY2024 · AI · contact PI
Investigation into the activation of multiple bnAb precursors using structure-designed immunogens and Ig knock-in mice$910,966
R01 · FY2024 · AI · contact PI
Investigation into the activation of multiple bnAb precursors using structure-designed immunogens and Ig knock-in mice$96,760
R01 · FY2024 · AI · contact PI
Refinement of DNA-Launched NanoParticles decorated with Apex and CD4bs B cell lineage targeting Envs (DLNP-ACEs)$1,163,370
U19 · FY2023 · AI · contact PI
Investigation into the activation of multiple bnAb precursors using structure-designed immunogens and Ig knock-in mice$843,126
R01 · FY2023 · AI · contact PI
Structural vaccinology guided development of a universal CoV vaccine utilizing nucleic acid delivered nanoparticles$2,626,814
P01 · FY2022 · AI
Development of broad nanovaccines targeting diverse coronavirus receptor-binding sites$1,244,471
P01 · FY2022 · AI · contact PI
Development of Broad Coronavirus Immunity Targeting the Fusion Peptide$228,788
R21 · FY2022 · AI · contact PI
Development of Broad Coronavirus Immunity Targeting the Fusion Peptide$274,544
R21 · FY2021 · AI · contact PI